Bristol-Myers Squibb (BMY)

Sector:Health Care
Super Investor Stats:
Ownership count:5
Ownership rank:89
% of all portfolios:0.123%
Hold Price * :$52.22
History Portfolio Manager Activity Share change % change to portfolio
Q2  2010
David Katz - Matrix Asset Advisors Reduce 8.33% 10,000 0.30
Q3  2009
Bill Nygren - Oakmark Select Fund Reduce 2.38% 100,000 0.11
Q1  2009
Bill Nygren - Oakmark Select Fund Reduce 10.50% 400,000 0.58
Richard Pzena - Hancock Classic Value Sell 100.00% 1,946,900 1.97
Q4  2008
Bill Nygren - Oakmark Select Fund Reduce 36.60% 2,200,000 2.94
Richard Pzena - Hancock Classic Value Reduce 56.66% 2,545,300 2.58
Q3  2008
Bill Nygren - Oakmark Select Fund Reduce 4.75% 300,000 0.26
Richard Pzena - Hancock Classic Value Reduce 18.48% 1,018,025 0.65
Q2  2008
Bill Nygren - Oakmark Select Fund Reduce 6.66% 450,000 0.33
Bruce Berkowitz - Fairholme Capital Sell 100.00% 11,069,200 4.25
Q1  2008
Bill Nygren - Oakmark Select Fund Reduce 8.77% 650,000 0.43
Dodge & Cox Sell 100.00% 15,529,395 0.66
Q4  2007
Bill Nygren - Oakmark Select Fund Reduce 2.63% 200,000 0.14
Richard Pzena - Hancock Classic Value Reduce 19.76% 1,356,900 0.60
Dodge & Cox Reduce 23.50% 4,770,955 0.20
Q3  2007
Bill Nygren - Oakmark Select Fund Reduce 8.20% 680,000 0.38
Q2  2007
Bill Nygren - Oakmark Select Fund Reduce 2.36% 200,000 0.11
Dodge & Cox Reduce 4.01% 848,500 0.04

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.